Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management

Transfusion

Volumn 43, Issue 5, 2003, Pages 584-590

  Kiely, Philip ^a   Stewart, Yvonne ^b   Castro, Lea ^b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOASSAY; PATIENT COUNSELING;

BLOOD; BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; FALSE POSITIVE REACTIONS; HEMATOLOGIC TESTS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HIV; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; IMMUNOASSAY; LONGITUDINAL STUDIES; VACCINATION;

EID: 0037407993     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00386.x     Document Type: Article

References (32)

1. Dodd RY, Houlihan K, Lamberson HV. The specificity of enzyme immunoassays for antibodies to human immunodeficiency virus: impact on record and donor management (letter). Transfusion 1993;33:693.
2. Kolho E, Farkkila M, Makinen J, et al. Clinical significance of hepatitis C antibodies in blood donors. J Med Virol 1994;43:129-34.
3. Jackson JB, Hanson MR, Johnson GM, et al. Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot. Transfusion 1995;35:98-102.
4. Buffington J, Shapiro CN, Holman RC, et al. Multiple unconfirmed-reactive screening tests for viral antibodies among blood donors. Transfusion 1994;34:371-5.
5. Sakugawa H, Nakasone H, Nakayoshi T, et al. High proportion of false positive reactions among donors with anti-HCV antibodies in a low prevalence area. J Med Virol 1995;46:334-8.
6. Sherman MP, Dock NL, Ehrlich GD, et al. Evaluation of HIV type 1 Western blot-indeterminate blood donors for the presence of human or bovine retroviruses. AIDS Res Human Retroviruses 1995;11:409-14.
7. Mclindon JP, Paver WK, Babbs C, et al. Hepatitis C-related chronic liver disease among asymptomatic blood donors in the north west of England. J Infect 1995;30:253-9.
8. Busch MP, Kleinman SH, Williams AE, et al. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Transfusion 1996;36:37-44.
9. Allain JP, Kitchen A, Aloysius S, et al. Safety and efficacy of hepatitis C virus antibody screening of blood donors with two sequential screening assays. Transfusion 1996; 36:401-5.
10. Bar-Shany S, Green MS, Shinar E. False positive tests for anti-hepatitis C antibodies and the problem of notifying blood donors. Int J Epidemiol 1996;25:674-8.
11. Dow BC, Buchanan I, Munro H, et al. Relevance of RIBA-3 supplementary test to HCV confirmation of blood donors. J Med Virol 1996;49:132-6.
12. Ownby HE, Korelitz JJ, Busch MP, et al. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Transfusion 1997;37:199-205.
13. Kleinman S, Busch MP, Hall L, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. JAMA 1998;280:1080-5.
14. Dow BC. 'Noise' in microbiological screening assays. Transfusion Med 2000;10:97-106.
15. Dodd RY, Stramer SL. Indeterminate results in blood donor testing: what you don't know can hurt you. Transfusion Med Rev 2000;14:151-60.
16. Busch MP. To thy (reactive) donors be true! Transfusion 1997;37:117-20.
17. Kiely P, Wilson D. Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management. Transfusion 2000;40:580-4.
18. Stewart Y, Tacey A, Kiely P. Comparison of Cambridge HTLV-I EIA and Murex HTLV-I/II EIA as supplemental assays when used with PRISM HTLV-I/II ChLIA as the primary screening assay (abstract). Presented at the 16th NRL Workshop on Serology, Melbourne 16-18 October, 1999 (poster no. 43).
19. Parry JV, Mortimer PP, Friderich P, et al. Faulty washers and soiled micropipettors may generate false positive serological results. Clin Diagnostic Virol 1997;7:173-81.
20. Pearlman ES, Ballas SK. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch Pathol Lab Med 1994;118:805-6.
21. Schupbach J, Baumgartner A, Tomasik Z. HTLV-I in Switzerland: low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors. Int J Cancer 1988;42:857-62.
22. Bazin R, Aubin E, Roberge C, et al. Molecular basis for the false positive reactions in HIV-1/2 enzyme immunoassays (abstract). Transfusion 2001;41(Suppl):79s.
23. Vardinon N, Yust I, Katz O, et al. Anti-HIV indeterminate Western blot in dialysis patients: a long term follow-up. Am J Kidney Dis 1999;34:146-9.
24. Willmam JH, Martins TB, Jaskowski TD, et al. Heterophile antibodies to bovine and caprine proteins causing false-positive human immunodeficiency virus type 1 and other enzyme-linked immunosorbent assay results. Clin Diagn Lab Immunol 1999;6:615-6.
25. Busch MP, Laycock M, Kleinman SH, et al. Accuracy of supplemental serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study. Blood 1994;83:1143-8.
26. Kloster B, Kramer R, Eastlund T, et al. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995;35:475-7.
27. Seed CR, Lee JF, Maloney R, et al. Hepatitis B surface antigenemia in blood donors after vaccination. Transfusion 1996;36:386.
28. Otag F, Mert A, Yilmaz G. Temporary deferral of blood donors after administration of hepatitis B vaccine. Transfusion 1997;37:880.
29. Dow BC, Munro H, Frame D, et al. Several assays show hepatitis B positivity soon after vaccination. BMJ 1998; 316:311.
30. Salker R, Howell DR, Moore MC, et al. Early acute hepatitis B infection and hepatitis B vaccination in blood donors. Transfusion Med 2001;11:463.
31. Dow BC, Yates P, Galea G, et al. Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen-positive blood donors. Vox Sang 2002;82:15-7.
32. Seed CR, Margaritis AR, Bolton WV, et al. Improved efficiency of national HIV, HCV and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 2003;43:226-34.